While investigating the association between expression of hub OS genes and SKCM clinical features, we discovered that patients with metastatic melanoma had significantly increased expression of AKAP9, VPS13C, and ACSL4 (Fig. 8I–K), while HMOX2 demonstrated higher expression in patients with primary melanoma (Fig. 8L). Here, AKAP9 is linked to metastatic melanoma.